Castres, France

Henri Lauressergues

This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre S.a.. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henri Lauressergues. Retrieved from https://idiyas.com/inventor/henri-lauressergues

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Henri Lauressergues: Innovator in Immunoactivators

Introduction

Henri Lauressergues is a notable inventor based in Castres, France. He has made significant contributions to the field of immunology through his innovative work on immunoactivators. His research focuses on developing new derivatives that can enhance immune responses.

Latest Patents

Henri Lauressergues holds a patent for "Immunoactivators derived from amino thiazoles." This invention concerns new derivatives of 4-phenyl 2-amino thiazole, where the formula includes variations in the substituent X, which can represent a hydrogen atom, a halogen, a lower alkyl, or an alkoxy. This patent showcases his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Lauressergues is associated with Pierre Fabre S.A., a prominent company in the pharmaceutical and dermo-cosmetic sectors. His work at this organization has allowed him to contribute to various innovative projects aimed at enhancing health and wellness.

Collaborations

Henri Lauressergues has collaborated with notable colleagues, including Jean-Pierre Tarayre and Henri Cousse. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of immunology.

Conclusion

Henri Lauressergues is a distinguished inventor whose work on immunoactivators has the potential to impact the medical field significantly. His dedication to innovation and collaboration continues to drive advancements in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…